Cullinan Therapeutics, Inc. CGEM
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +45.22%
- 1 year
- +98.81%
- Open
- 15.38
- Prev close
- 15.45
- Mkt cap
- 967.25M
- Vol
- 389.42K
- Avg vol
- 905.33K
- EPS
- -3.11
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 14.70
- High
- 15.72
- Forward P/E
- -6.30
- Beta
- -0.04
- Short ratio
- 6.17
- Inst. own
- 112.54%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 18.28
- 200-d avg
- 15.74
- 1y target
- 34.60
5D chart
Events in this range
- Oct 28, 2026Rating: BTIG · Buy → Buy
Signals (122)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 29, 3:50 PM | 2 days ago |
| RSI: Oversold | Oct 29, 3:20 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:15 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 2:55 PM | 2 days ago |
| RSI: Oversold | Oct 29, 2:15 PM | 2 days ago |
| RSI: Oversold | Oct 29, 2:05 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:55 PM | 2 days ago |
| SMA: Bearish | Oct 29, 11:40 AM | 2 days ago |
| SMA: Bearish | Oct 29, 11:25 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:05 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:50 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 10:45 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:40 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:35 AM | 2 days ago |
| RSI: Overbought | Oct 29, 9:50 AM | 2 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 2 days ago |
| MACD: Buy Signal | Oct 28, 3:30 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:10 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:05 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:05 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:00 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:15 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 2:15 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:05 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:05 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 2:00 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:50 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:45 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:45 PM | 3 days ago |
| SMA: Bearish | Oct 28, 11:50 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:50 AM | 3 days ago |
| RSI: Overbought | Oct 28, 11:40 AM | 3 days ago |
| RSI: Overbought | Oct 28, 11:15 AM | 3 days ago |
| RSI: Overbought | Oct 28, 10:40 AM | 3 days ago |
| RSI: Overbought | Oct 28, 10:25 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 9:55 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:50 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:45 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 9:35 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 9:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 27, 3:45 PM | 4 days ago |
| SMA: Bullish | Oct 27, 3:30 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:30 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 3:25 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:20 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 2:20 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:10 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 1:40 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:35 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 1:25 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:20 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:15 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:00 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:20 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:15 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:10 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:05 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:00 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 11:50 AM | 4 days ago |
| SMA: Bullish | Oct 27, 11:25 AM | 4 days ago |
| SMA: Bearish | Oct 27, 11:05 AM | 4 days ago |
| RSI: Overbought | Oct 27, 10:45 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:15 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 10:15 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:05 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 9:50 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:45 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:45 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:40 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:35 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 26, 3:45 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:30 PM | 5 days ago |
| SMA: Bearish | Oct 26, 3:20 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:15 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:35 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:35 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 2:35 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 2:10 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:05 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:45 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:45 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 1:45 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 1:20 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:00 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:00 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:55 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:55 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:35 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:35 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:15 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:05 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:05 PM | 5 days ago |
| SMA: Bullish | Oct 26, 11:55 AM | 5 days ago |
| SMA: Bullish | Oct 26, 11:55 AM | 5 days ago |
| SMA: Bearish | Oct 26, 11:45 AM | 5 days ago |
| SMA: Bearish | Oct 26, 11:45 AM | 5 days ago |
| SMA: Bullish | Oct 26, 11:10 AM | 5 days ago |
| SMA: Bearish | Oct 26, 10:40 AM | 5 days ago |
| MACD: Sell Signal | Oct 26, 10:30 AM | 5 days ago |
| SMA: Bearish | Oct 26, 10:25 AM | 5 days ago |
| RSI: Overbought | Oct 26, 10:15 AM | 5 days ago |
| SMA: Bullish | Oct 26, 10:10 AM | 5 days ago |
| SMA: Bullish | Oct 26, 9:30 AM | 5 days ago |
| RSI: Overbought | Oct 26, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 23, 3:55 PM | 1 week ago |
| SMA: Bullish | Oct 23, 3:10 PM | 1 week ago |
| MACD: Buy Signal | Oct 23, 3:10 PM | 1 week ago |
| SMA: Bullish | Oct 23, 2:50 PM | 1 week ago |
| SMA: Bearish | Oct 23, 2:00 PM | 1 week ago |
| MACD: Sell Signal | Oct 23, 1:55 PM | 1 week ago |
| SMA: Bearish | Oct 23, 1:50 PM | 1 week ago |
| SMA: Bullish | Oct 23, 1:10 PM | 1 week ago |
| SMA: Bullish | Oct 23, 12:35 PM | 1 week ago |
| SMA: Bearish | Oct 23, 12:30 PM | 1 week ago |
| SMA: Bullish | Oct 23, 11:40 AM | 1 week ago |
| SMA: Bearish | Oct 23, 11:35 AM | 1 week ago |
| SMA: Bullish | Oct 23, 11:30 AM | 1 week ago |
| RSI: Oversold | Oct 23, 10:45 AM | 1 week ago |
| SMA: Bullish | Oct 23, 10:40 AM | 1 week ago |
News
2 days ago zacks.com
Does Cullinan Therapeutics (CGEM) Have the Potential to Rally 129.63% as Wall Street Analysts Expect?
The mean of analysts' price targets for Cullinan Therapeutics (CGEM) points to a 129.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong…
3 days ago marketbeat.com
3 Growth Stocks Under $20 With Hard Catalyst Dates Ahead
Small caps led the market into spring and have been handing it back ever since. The Russell 2000 has cooled, defense and drone names sit well off their highs, and the riskier corners of biotech and…
-
3 days ago benzinga.com
BTIG Maintains Buy on Cullinan Therapeutics, Raises Price Target to $41
BTIG analyst Julian Harrison maintains Cullinan Therapeutics (NASDAQ:CGEM) with a Buy and raises the price target from $40 to $41.
-
4 days ago benzinga.com
Cullinan Therapeutics Gets FDA And Australian Therapeutic Goods Administration Clearance To Initiate Its Global Phase 1b/2a Clinical Trial In Adults With Relapsing And Refractory ITP And Warm Autoimmune Hemolytic Anemia
Global regulatory clearances in the U.S. and Australia support initiation of a Phase 1b/2a study in relapsing and refractory ITP and wAIHAStudy expands immunology portfolio into autoimmune…
4 days ago globenewswire.com
Cullinan Therapeutics Advances Velinotamig into Global Clinical Development for Autoimmune Cytopenias Following IND Clearance by the U.S. FDA
Global regulatory clearances in the U.S. and Australia support initiation of a Phase 1b/2a study in relapsing and refractory ITP and wAIHA
-
1 week ago benzinga.com
BTIG Reiterates Buy on Cullinan Therapeutics, Maintains $40 Price Target
BTIG analyst Julian Harrison reiterates Cullinan Therapeutics (NASDAQ:CGEM) with a Buy and maintains $40 price target.
-
1 week ago benzinga.com
Taiho Oncology and Cullinan Therapeutics Say Data From Cohort C Of Phase 2 REZILIENT2 Trial Of Zipalertinib For Locally Advanced Or Metastatic Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Or Uncommon EGFR Mutations and Active CNS Metastases Shows Intracranial Objective Response Rate Of 30.2% In 43 Evaluable Patients
Taiho Oncology, Inc. and Cullinan Therapeutics, Inc. (NASDAQ:CGEM) today announced results from Cohort C of the Phase 2 REZILIENT2 trial evaluating zipalertinib monotherapy in patients with locally…
-
4 weeks ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Cullinan Therapeutics, Maintains $35 Price Target
HC Wainwright & Co. analyst Robert Burns reiterates Cullinan Therapeutics (NASDAQ:CGEM) with a Buy and maintains $35 price target.
-
1 month ago benzinga.com
Reported Earlier, Cullinan Therapeutics Initiates NDA Submission For Zipalertinib Plus Chemotherapy In First-Line EGFR Exon 20 Insertion NSCLC Under FDA RTOR Program After Phase 3 REZILIENT3 Trial Met Primary Endpoint
In the Phase 3 REZILIENT3 study, zipalertinib combination therapy demonstrated longest median progression-free survival observed to date in first-line EGFR exon20ins NSCLC After agreement with the…